Total Intravenous Anesthesia with Propofol Reduces Postoperative Nausea and Vomiting in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy: A Prospective Randomized Trial
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: We investigated the effect of total intravenous anesthesia (TIVA) with propofol on postoperative nausea and vomiting (PONV) after robot-assisted laparoscopic radical prostatectomy (RLRP) in patients at low risk of developing PONV, in comparison to balanced anesthesia with desflurane. Materials and Methods: Sixty two patients were randomly assigned to the Des or TIVA group. Propofol and remifentanil were used for induction of anesthesia in both groups and for maintenance of the anesthesia in the TIVA group. In the Des group, anesthesia was maintained with desflurane and remifentanil. In both groups, postoperative pain was controlled using fentanyl-based intravenous patient controlled analgesia,and ramosetron 0.3 mg was administered at the end of surgery. The incidence of PONV, severity of nausea and pain, and requirements of rescue antiemetics and analgesics were recorded. Results: The incidence of nausea in the post-anesthetic care unit was 22.6% in the Des group and 6.5% in the TIVA (p=0.001) group. The incidence of nausea at postoperative 1-6 hours was 54.8% in the Des group and 16.1% in the TIVA group (p=0.001). At postoperative 6-48 hours, there were no significant differences in the incidence of nausea between groups. Conclusion: In order to prevent PONV after RLRP in the early postoperative period, anesthesia using TIVA with propofol is required regardless of patient-related risk factors.
Abstract
Purpose: We investigated the effect of total intravenous anesthesia (TIVA) with propofol on postoperative nausea and vomiting (PONV) after robot-assisted laparoscopic radical prostatectomy (RLRP) in patients at low risk of developing PONV, in comparison to balanced anesthesia with desflurane. Materials and Methods: Sixty two patients were randomly assigned to the Des or TIVA group. Propofol and remifentanil were used for induction of anesthesia in both groups and for maintenance of the anesthesia in the TIVA group. In the Des group, anesthesia was maintained with desflurane and remifentanil. In both groups, postoperative pain was controlled using fentanyl-based intravenous patient controlled analgesia,and ramosetron 0.3 mg was administered at the end of surgery. The incidence of PONV, severity of nausea and pain, and requirements of rescue antiemetics and analgesics were recorded. Results: The incidence of nausea in the post-anesthetic care unit was 22.6% in the Des group and 6.5% in the TIVA (p=0.001) group. The incidence of nausea at postoperative 1-6 hours was 54.8% in the Des group and 16.1% in the TIVA group (p=0.001). At postoperative 6-48 hours, there were no significant differences in the incidence of nausea between groups. Conclusion: In order to prevent PONV after RLRP in the early postoperative period, anesthesia using TIVA with propofol is required regardless of patient-related risk factors.
참고문헌 (30)
- Zorn KC, "Robotic-assisted laparoscopic prostatectomy: functional and pathologic outcomes with interfascial nerve preservation", Eur Urol, 51, pp.755~762 (2007)
- 정재형, "Initial Clinical Experience of Simultaneous Robot-Assisted Bilateral Partial Nephrectomy and Radical Prostatectomy", Yonsei Medical Journal, 53(1), pp.236~239 (2012), 연세대학교의과대학
- Meininger D, "Effects of prolonged pneumoperitoneum on hemodynamics and acid-base balance during totally endoscopic robot-assisted radical prostatectomies", World J Surg, 26, pp.1423~1427 (2002)
- Iitomi T, "Incidence of nausea and vomiting after cholecystectomy performed via laparotomy or laparoscopy", Masui, 44, pp.1627~1631 (1995)
- Watcha MF, "Postoperative nausea and vomiting. Its etiology, treatment, and prevention", Anesthesiology, 77, pp.162~184 (1992)
- Kovac AL, "Prevention and treatment of postoperative nausea and vomiting", Drugs, 59, pp.213~243 (2000)
- Chen X, "The effect of timing of dolasetron administration on its efficacy as a prophylactic antiemetic in the ambulatory setting", Anesth Analg, 93, pp.906~911 (2001)
- Gold BS, "Unanticipated admission to the hospital following ambulatory surgery", JAMA, 262, pp.3008~3010 (1989)
- Apfel CC, "A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers", Anesthesiology, 91, pp.693~700 (1999)
- Lebenbom-Mansour MH, "Desflurane versus propofol anesthesia: a comparative analysis in outpatients", Anesth Analg, 76, pp.936~941 (1993)
- Gupta A, "Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review", Anesth Analg, 98, pp.632~641 (2004)
- Fujii Y, "Management of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy", Surg Endosc, 25, pp.691~695 (2011)
- Habib AS, "Evidence-based management of postoperative nausea and vomiting: a review", Can J Anaesth, 51, pp.326~341 (2004)
- White PF, "POST-OP Study Group. The impact of current antiemetic practices on patient outcomes: a prospective study on high-risk patients", Anesth Analg, 107, pp.452~458 (2008)
- Apfel CC, "A factorial trial of six interventions for the prevention of postoperative nausea and vomiting", N Engl J Med, 350, pp.2441~2451 (2004)
- Marsh B, "Pharmacokinetic model driven infusion of propofol in children", Br J Anaesth, 67, pp.41~48 (1991)
- Minto CF, "Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development", Anesthesiology, 86, pp.10~23 (1997)
- Fanelli G, "Fast-track anaesthesia for laparoscopic cholecystectomy: a prospective, randomized, multicentre, blind comparison of desflurane-remifentanil or sevoflurane-remifentanil", Eur J Anaesthesiol, 23, pp.861~868 (2006)
- Khan JS, "Laparoscopic cholecystectomy; common bile duct injury after learning curve", Professional Med J, 17, pp.373~378 (2010)
- Barann M, "Inhibition by anaesthetics of 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells", Naunyn Schmiedebergs Arch Pharmacol, 347, pp.125~132 (1993)
- Vasileiou I, "Propofol: a review of its non-anaesthetic effects", Eur J Pharmacol, 605, pp.1~8 (2009)
- Appadu BL, "Does propofol interact with D2 dopamine receptors?", Anesth Analg, 79, pp.1191~1192 (1994)
- Sneyd JR, "A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents", Eur J Anaesthesiol, 15, pp.433~445 (1998)
- Fredman B, "Sevoflurane for outpatient anesthesia: a comparison with propofol", Anesth Analg, 81, pp.823~828 (1995)
- Graham SG, "A comparison between propofol and desflurane anaesthesia for minor gynaecological laparoscopic surgery", Anaesthesia, 48, pp.471~475 (1993)
- Tramèr M, "Propofol anaesthesia and postoperative nausea and vomiting: quantitative systematic review of randomized controlled studies", Br J Anaesth, 78, pp.247~255 (1997)
- Apfel CC, "Volatile anaesthetics may be the main cause of early but not delayed postoperative vomiting: a randomized controlled trial of factorial design", Br J Anaesth, 88, pp.659~668 (2002)
- Naylor RJ, "The physiology and pharmacology of postoperative nausea and vomiting", Anaesthesia, 49(Suppl), pp.2~5 (1994)
- Gecaj-Gashi A, "Propofol vs isoflurane anesthesia-incidence of PONV in patients at maxillofacial surgery", Adv Med Sci, 55, pp.308~312 (2010)
- Grundmann U, "Total intravenous anaesthesia with propofol and remifentanil in paediatric patients: a comparison with a desflurane-nitrous oxide inhalation anaesthesia", Acta Anaesthesiol Scand, 42, pp.845~850 (1998)